Undisclosed Ocular Program(s)
Degenerative Eye Disease (e.g., AMD, Retinitis Pigmentosa)
Pre-clinicalActive
Key Facts
Indication
Degenerative Eye Disease (e.g., AMD, Retinitis Pigmentosa)
Phase
Pre-clinical
Status
Active
Company
About CiRC Biosciences
CiRC Biosciences is a private, early-stage biotech founded in 2021, headquartered in Cambridge, Massachusetts, with a listed address in Chicago, Illinois. The company is pioneering a cellular reprogramming platform to address degenerative diseases characterized by cell loss, such as those causing vision loss. Operating in the high-risk, high-reward space of regenerative medicine, CiRC is pre-clinical and pre-revenue, positioning itself to tackle significant unmet medical needs where traditional therapeutic targets are absent. The company's success hinges on validating its platform and advancing its initial programs into clinical development.
View full company profile